Oxygen Biotherapeutics ousts CEO Stern "for cause", following internal investigation
26 August 2011
Nancy Faigen
Please Login to read the full article.
26 August 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Stockwatch: The impossible takes a little too long
- Napo wins small battle in crofelemer dispute, but war rages on with Salix
- Study nudges Abbott's Duodopa towards US approval but Ph III pardoprunox is dumped
- Argos passes on IPO and raises $25m Series D to fund personalized cancer immunotherapy
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
